Most material used for control and calibration in a clinical laboratory is based on pool sera of human origin, guaranteed to be HBsAg-free. Since little Information is available on the potential infectivity of HIV, the causative agent of acquired immunodeficiency syndrome (AIDS), 54 control and calibration sera, in routine use, were investigated for the incidence of antibodies to HIV by means of Elisa. Sixteen test specimens (= 30%) gave positive or borderline Elisa results and were further analysed by immunoblotting, resulting in 15 samples all recognizing gp 160 and partially the p 24, p 31, p 55, p 64 and gp 120 band. Only one sample with borderline Elisa result was negative by this assay. Furthermore, all sera were examined for the presence of viral antigen by a solid phase Elisa. All samples under investigation gave negative antigen Elisa results. Bearing in miiid that the sensitivity of this assay is limited to 10 g/l of viral antigen, no conclusion on infectivity should be drawn. The high incidence of HlV-antibodies in the sera investigated demands that this material should be handled with special care by laboratory personnel.
Introduction
The acquired immunodeficiency syndrome (AIDS) (1) is a rather recently described disease primarily affecting certain risk groups like promiscuous homosexuals, drug addicts and haemöphiliacs who have received clotting concentrates, which have not been tested for HlV-antibödies or inactivated by heat, and the sexual partners of these groups (2) (3) (4) . The causative agent has been described äs a human retrovirus designated Human T lyjnphotrqpic vifus type III/lymphadenopathy associated virus (HTLV III/ LAV) (5, 6) ; in the new nomenclature it is called human immunodeficiency virus (HIV). All available evidence suggests that transmission of the virus occurs predominantly through contact with blood äs well äs blood derivates. However, the virus has also been isolated from other body flüids like urine or saliva of infected persons (7) .
Health workers and laboratory staff are caring for an increasing number of patients, infected with HIV, and there is concera regarding their risk of infection from casual or percutaneous occasional exposure to the virus (8, 9) . In spite of a low transmission rate of HIV infection documented within this group of persons (10, 11) , the continuation of precautions regarding the handling of body flüids is recommended and emphasized. Therefore in Austria all specimens for laboratory investigations that are suspected to come from HIV-positive individuals have to be marked yellow/red, for handling with special care by laboratory staff.
For control and calibration purposes materials from human sources are generally preferred, in order to maintain the same matrix äs the test specimen of interest. For this purpose most vendors provide preparations tested for HBsAg, to minimize the potential risk of hepatitis B infection. Only partial Information is available on the incidence of antibodies to HIV in quality assurance sera routinely used in laboratories and their potential risk of HIV transmission. Therefore all contrpl and calibration sera used in this laboratory were investigated for antibodies to HIV by an enzyme linked inumunosorbent assay (Elisa). Since testing for anti HIV antibodies by Elisa may give false positives, screening results have to be confirmed by immunoblot analysis. Because reactivity in these assays indicates antibody presence, but not viral infectivity, all sera were tested for the evidence of viral particles using an HIV antigen Elisa.
Materials and Methods
Quality assurance reagents A total of 54 quality assurance reagents were obtained from the following companies: 
Elisa screening for anti HIV antibodies
All control sera and calibrators listed above were investigated by use of a Du Pont HIV Elisa kit (Du Pont). The assay was performed according to the manufacturers instructions. oPhenylene-diamine was used äs the chromogenic Substrate, and absorbance (A) was read at 410 nm using a Dynatec Elisa reader within two hours after stopping the peroxidase reaction. All samples were tested in duplicate.
The cut off for reactivity was that recommended by the manufacturer, calculated äs the mean absorbance of the positive controls divided by two (experiment 1: 0.680 A, experiment 2: 0.445 A), all values above were considered to be positive. Step with an avidin-peroxidase conjugate. 2-Chloro-1-naphthpl was used äs the chromogen, giving a purpleblue reaction product.
Detection of HIV viral antigen
For the demonstration of HIV Viral antigen, a sandwich solid phase enzyme immuno assay (Abbott) was performed, following the manufacturers instructions. The chromogenic Substrate for the peroxidase reaction was 0-phenylene-diamine. The cut off for reactivity was calculated by adding 0.050 to the mean absorbance value of the three negative contfols äs recommended by the manufactürer. All samples were tested in duplicate and absorbance values equal to or greater than the calculated cut off value were considered reactive for HIV antigen.
Results
In this study a total fo 54 control sera and calibrators was tested for anti HIV antibody by means of Elisa. Sixteen sera (= 30%) gave positive or borderline positive Elisa results (experiment l, cut off 0. 
Discussion
For quality assurance sera originating from human material, the number of donors may be 6000 or more. Although pools are tested for HBsAg, donors are often members of risk groups for HIV infection. Therefore 54 control sera and calibrators routinely used in this laboratory were tested for aiitibodies to HIV. Elisa screening gave about 30% reactive samples. These data are in agreement with Howanitz et al. (12), who reported the presence of HIV antibodies in about 31% of quality assurance sera on the basis of initial tests. However, 7 of 45 reactive samples in this study were nonreactive on repeated testing. In our study, 15 of the 16 positive or borderline Elisa results were confirmed by immunoblot analysis, indicating that the observed Elisa reactivity was not due to preparation artefacts. The one sample giving a negative immunoblot result had also shown absorbance values close to the extended cut off value. The fact that gp 41 could only be found in two of the 15 positively reactive sera investigated may be due to the dilution effect, since all these quality assurance materials are produced from pool sera, and this band is weaker than the others even in strongly positive cases. However, gp 160, which is known to be the - viral protein to which the highest titers of antibodies are mounted, gave the strongest reactivity in all samples. Moreover, all 54 samples were tested for viral antigen, but no positivity was observed. However, titratiön of viral antigen using this Elisa procedure showed sensitivity down tö concentrations of 10 § antigen per l diluent only. Therefore no conclusions can be drawn regarding the infectivity of the samples tested, because the amount of infectious agent may be beneath the quäntities detectable by the antigen Elisa. In high percentages of haemophiliacs receiving eommercial clotting concentrates which have not been tested for anti-HIV antibodies and heat inactivated, transmission of the virus has been described, resulting in the development of antibodies to HIV and exacerbation of AIDS (13, 14, 15) . HIV has been isolated from peripheral blood and other body fluids of most patients with pre-AIDS, and from a considerable number of patients with the fully developed picture of AIDS. The virus has been isolated from lyophilized factor VIII concentrates (16) , indicating that the virus is resistant to the lyophilization procedure.
These results strengthen the case for h.andling all control sera with special care, and according to the safety precautions against hepatitis B infection, which will also protect against HIV infection (17) . Since methods are now available for testing sera for the presence of aiiti HIV antibodies, and, furtherinore, rather mild procedures for inactivating the virus have been established (18) , vendors shoüld be obliged to provide control and calibration materials which are anti HIV antibody-üegative, in order to lower the potential risk for laboratory personnel.
